Research overview
What is FOXO4-DRI?
FOXO4 is a transcription factor implicated in survival of some senescent cells. FOXO4-DRI is an engineered peptide investigated for interfering with its interaction with p53. The “DRI” design refers to a D-retro-inverso strategy; the label does not independently verify that a supplied peptide has the studied structure.
What has research examined?
A foundational paper reported selective apoptosis of senescent cells under tested culture conditions and improvements in selected tissue and functional measurements in accelerated-aging and naturally aged mice. Another experiment examined senescent Leydig cells and testosterone-related measures in aged mice. These preclinical settings do not establish prevention of human aging, broader selectivity, or long-term safety.
Removing senescent cells in selected experimental models is not a validated human healthspan outcome. Off-target effects and translation to people remain unresolved. No preparation, amount, schedule, or use is recommended.
Research references
- Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and AgingCell
- FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged miceAging; cell and mouse study
Calculation boundary
The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.